Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Steven

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Parasites & Vectors|October 24, 2014
A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasisAlice Halliday, Ana F Guimaraes, Hayley E Tyrer, et al.
Life (Basel, Switzerland)|October 27, 2022
<i>Aeromonas allosaccharophila</i> Strain AE59-TE2 Is Highly Antagonistic towards Multidrug-Resistant Human Pathogens, What Does Its Genome Tell Us?Sheila da Silva, Fernanda Alves de Freitas Guedes, João Ricardo Vidal Amaral, et al.
Plos Neglected Tropical Diseases|August 18, 2020
Generation of Loa loa infective larvae by experimental infection of the vector, Chrysops silaceaLontum B Ndzeshang, Fanny F Fombad, Abdel J Njouendou, et al.
Scientific Reports|March 22, 2016
Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasisRaman Sharma, Ghaith Al Jayoussi, Hayley E Tyrer, et al.
Scientific Reports|January 9, 2018
Corrigendum: Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasisRaman Sharma, Ghaith Aljayyoussi, Hayley E Tyrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
Albendazole and antibiotics synergize to deliver short-course anti-<i>Wolbachia</i> curative treatments in preclinical models of filariasisJoseph D Turner, Raman Sharma, Ghaith Al Jayoussi, et al.
Frontiers in Microbiology|February 16, 2024
Combinations of the azaquinazoline anti-<i>Wolbachia</i> agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasisShrilakshmi Hegde, Amy E Marriott, Nicolas Pionnier, et al.
Scientific Reports|March 18, 2017
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
Scientific Reports|January 20, 2018
Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
ACS Infectious Diseases|April 2, 2021
Structural Requirements for Dihydrobenzoxazepinone Anthelmintics: Actions against Medically Important and Model Parasites: <i>Trichuris muris</i>, <i>Brugia malayi</i>, <i>Heligmosomoides polygyrus</i>, and <i>Schistosoma mansoni</i>Frederick A Partridge, Carole J R Bataille, Ruth Forman, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Parasites & Vectors|October 24, 2014
A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasisAlice Halliday, Ana F Guimaraes, Hayley E Tyrer, et al.
Life (Basel, Switzerland)|October 27, 2022
<i>Aeromonas allosaccharophila</i> Strain AE59-TE2 Is Highly Antagonistic towards Multidrug-Resistant Human Pathogens, What Does Its Genome Tell Us?Sheila da Silva, Fernanda Alves de Freitas Guedes, João Ricardo Vidal Amaral, et al.
Plos Neglected Tropical Diseases|August 18, 2020
Generation of Loa loa infective larvae by experimental infection of the vector, Chrysops silaceaLontum B Ndzeshang, Fanny F Fombad, Abdel J Njouendou, et al.
Scientific Reports|March 22, 2016
Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasisRaman Sharma, Ghaith Al Jayoussi, Hayley E Tyrer, et al.
Scientific Reports|January 9, 2018
Corrigendum: Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasisRaman Sharma, Ghaith Aljayyoussi, Hayley E Tyrer, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 29, 2017
Albendazole and antibiotics synergize to deliver short-course anti-<i>Wolbachia</i> curative treatments in preclinical models of filariasisJoseph D Turner, Raman Sharma, Ghaith Al Jayoussi, et al.
Frontiers in Microbiology|February 16, 2024
Combinations of the azaquinazoline anti-<i>Wolbachia</i> agent, AWZ1066S, with benzimidazole anthelmintics synergise to mediate sub-seven-day sterilising and curative efficacies in experimental models of filariasisShrilakshmi Hegde, Amy E Marriott, Nicolas Pionnier, et al.
Scientific Reports|March 18, 2017
Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
Scientific Reports|January 20, 2018
Author Correction: Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and OnchocerciasisGhaith Aljayyoussi, Hayley E Tyrer, Louise Ford, et al.
ACS Infectious Diseases|April 2, 2021
Structural Requirements for Dihydrobenzoxazepinone Anthelmintics: Actions against Medically Important and Model Parasites: <i>Trichuris muris</i>, <i>Brugia malayi</i>, <i>Heligmosomoides polygyrus</i>, and <i>Schistosoma mansoni</i>Frederick A Partridge, Carole J R Bataille, Ruth Forman, et al.
Pageof 6